- Home
- IPSC vs NDLS Comparison
IPSC vs NDLS Comparison
Compare IPSC & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- NDLS
- Stock Information
- Founded
- IPSC 2019
- NDLS 1995
- Country
- IPSC United States
- NDLS United States
- Employees
- IPSC 165
- NDLS N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- NDLS Restaurants
- Sector
- IPSC Health Care
- NDLS Consumer Discretionary
- Exchange
- IPSC Nasdaq
- NDLS Nasdaq
- Market Cap
- IPSC 49.6M
- NDLS 45.2M
- IPO Year
- IPSC 2021
- NDLS 2013
- Fundamental
- Price
- IPSC $0.58
- NDLS $0.79
- Analyst Decision
- IPSC Strong Buy
- NDLS Strong Buy
- Analyst Count
- IPSC 5
- NDLS 2
- Target Price
- IPSC $3.33
- NDLS $3.00
- AVG Volume (30 Days)
- IPSC 868.9K
- NDLS 153.2K
- Earning Date
- IPSC 08-07-2025
- NDLS 08-06-2025
- Dividend Yield
- IPSC N/A
- NDLS N/A
- EPS Growth
- IPSC N/A
- NDLS N/A
- EPS
- IPSC N/A
- NDLS N/A
- Revenue
- IPSC $114,898,000.00
- NDLS $495,670,000.00
- Revenue This Year
- IPSC $1,064.82
- NDLS $5.37
- Revenue Next Year
- IPSC N/A
- NDLS $0.68
- P/E Ratio
- IPSC N/A
- NDLS N/A
- Revenue Growth
- IPSC 8286.72
- NDLS N/A
- 52 Week Low
- IPSC $0.34
- NDLS $0.55
- 52 Week High
- IPSC $3.29
- NDLS $2.18
- Technical
- Relative Strength Index (RSI)
- IPSC 52.16
- NDLS 44.78
- Support Level
- IPSC $0.58
- NDLS $0.76
- Resistance Level
- IPSC $0.66
- NDLS $0.82
- Average True Range (ATR)
- IPSC 0.04
- NDLS 0.06
- MACD
- IPSC -0.00
- NDLS 0.00
- Stochastic Oscillator
- IPSC 41.52
- NDLS 25.00
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.